ANKRD30A, ankyrin repeat domain 30A, 91074

N. diseases: 36; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 AlteredExpression group BEFREE The novel breast cancer associated antigen NY-BR-1 was identified by SEREX analysis and is expressed in the majority (>70%) of breast tumors as well as metastases, in normal breast tissue, in testis and occasionally in prostate tissue. 27863482 2016
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 AlteredExpression group BEFREE Corroborating methodologies, including mRNA quantitation and immunoblotting show that NY-BR-1 is strongly expressed in >70% of 129 breast tumors. 17330232 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 AlteredExpression group LHGDN Corroborating methodologies, including mRNA quantitation and immunoblotting show that NY-BR-1 is strongly expressed in >70% of 129 breast tumors. 17330232 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 Biomarker group BEFREE T-cell clones specific for one of the NY-BR-1 epitopes (p904) also recognized breast tumor cells expressing NY-BR-1, NY-BR-1(-) cells transfected with a cDNA encoding the NY-BR-1 protein, and autologous dendritic cells pulsed with opsonized NY-BR-1+ breast tumor cells. 16818660 2006